Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dermatophagoides farinae allergen-specific T-cell receptors (TCRs) are specialized heterodimeric surface proteins expressed on CD4+ T lymphocytes that mediate the adaptive immune response to house dust mite (HDM) allergens. These receptors specifically recognize peptide fragments derived from D. farinae proteins, such as the major allergens Der f 1 and Der f 2, when presented by Human Leukocyte Antigen (HLA) class II molecules on the surface of antigen-presenting cells [PMID: 28433314]. In sensitized individuals, the binding of these TCRs to the peptide-HLA complex triggers a Th2-polarized inflammatory response, leading to the production of pro-allergic cytokines and allergen-specific IgE, which are central to the pathogenesis of allergic asthma, rhinitis, and atopic dermatitis [PMID: 31009711, PMID: 26231558]. Therapeutic strategies targeting these TCR-mediated pathways, such as allergen-specific immunotherapy (AIT), aim to reprogram the immune system toward a state of tolerance by inducing T-cell anergy or promoting the expansion of regulatory T cells [PMID: 30243710]. The characterization of these TCRs using MHC-peptide tetramers and repertoire sequencing provides critical insights into the mechanisms of desensitization and serves as a valuable tool for monitoring treatment efficacy in precision allergy medicine [PMID: 25652135].
Modulation of T-cell signaling through repeated allergen exposure to induce peripheral tolerance, characterized by T-cell anergy, deletion of Th2 cells, or the induction of regulatory T cells (Tregs) that secrete suppressive cytokines like IL-10 and TGF-beta [PMID: 30243710].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dermatophagoides farinae allergen-specific T-cell receptor (Der f-specific TCR).